Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.

× No keyword cloud information.

9 in total

1. CONTROLLED STUDIES OF THE THERAPY OF NONRESECTABLE CANCER OF THE LUNG. I. METHODOLOGY.

Authors: J WOLF
Journal: Ann Thorac Surg Date: 1965-01 Impact factor: 4.330

2. THE EFFECT OF DIFFERING DEMANDS FOR BLOOD CELL PRODUCTION ON DNA SYNTHESIS BY HEMOPOIETIC COLONY-FORMING CELLS OF MICE.

Authors: A J BECKER; E A MCCULLOCH; L SIMINOVITCH; J E TILL
Journal: Blood Date: 1965-09 Impact factor: 22.113

3. Nitrogen mustard and the steroid hormones in the treatment of inoperable bronchogenic carcinoma.

Authors: J WOLF; P SPEAR; R YESNER; M E PATNO
Journal: Am J Med Date: 1960-12 Impact factor: 4.965

4. [Pharmacological characterization of cyclic nitrogen mustard phosphamide esters as cancer therapeutic agents].

Authors: N BROCK
Journal: Arzneimittelforschung Date: 1958-01

5. Determination of human body surface area from height and weight.

Authors: J SENDROY; L P CECCHINI
Journal: J Appl Physiol Date: 1954-07 Impact factor: 3.531

6. Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine.

Authors: F A Valeriote; W R Bruce
Journal: J Natl Cancer Inst Date: 1967-03 Impact factor: 13.506

7. Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil.

Authors: W R Bruce; B E Meeker
Journal: J Natl Cancer Inst Date: 1967-03 Impact factor: 13.506

8. Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

Authors: W R Bruce; B E Meeker; F A Valeriote
Journal: J Natl Cancer Inst Date: 1966-08 Impact factor: 13.506

9. An in vitro assay for growth-inhibiting activity of vinblastine.

Authors: F A Valeriote; W R Bruce
Journal: J Natl Cancer Inst Date: 1965-11 Impact factor: 13.506

9 in total

7 in total

1. Burkitt's lymphoma in Ibadan: hematologic response to single, large, intravenous dose of cyclophosphamide. Case reports.

Authors: J I Durodola
Journal: J Natl Med Assoc Date: 1976-05 Impact factor: 1.798

Review 2. Clinical pharmacokinetics of cyclophosphamide.

Authors: L B Grochow; M Colvin
Journal: Clin Pharmacokinet Date: 1979 Sep-Oct Impact factor: 6.447

Review 3. An assessment of massive-dose chemotherapy of malignant disease.

Authors: D E Bergsagel
Journal: Can Med Assoc J Date: 1971-01-09 Impact factor: 8.262

4. Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.

Authors: H P Lohrmann; W Schreml; T M Fliedner; H Heimpel
Journal: Blut Date: 1979-01-22

Review 5. Clinical pharmacokinetics of cyclophosphamide.

Authors: Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 5.577

Review 6. Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Authors: Rita Diehl; Fabienne Ferrara; Claudia Müller; Antje Y Dreyer; Damian D McLeod; Stephan Fricke; Johannes Boltze
Journal: Cell Mol Immunol Date: 2016-10-10 Impact factor: 11.530

Review 7. Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis.

Authors: Koyal Jain; Pankaj Jawa; Vimal K Derebail; Ronald J Falk
Journal: Kidney360 Date: 2021-04-29

7 in total